Deze pagina is beschikbaar is meerdere talen
Select Language

IPO Valbiotis

Back

Playing this video will load a content from YouTube, a service of Google LLC. For information on how Google may use your data, see the Google privacy policy.


Accept cookies

Listing of Valbiotis on Euronext

Sébastien Peltier, CEO of Valbiotis, opens the trading day in Paris.

Valbiotis is a biopharmaceutical company specializing in the research and development of preventive and therapeutic products based on polymolecular complexes indicated at specific stages of progression of chronic metabolic pathologies such as type 2 diabetes, obesity, dyslipidemia or NASH (Non-Alcoholic Steatosis Hepatic).